122 related articles for article (PubMed ID: 38186079)
1. Regulation of mast cells by overlapping but distinct protein interactions of Siglec-6 and Siglec-8.
Korver W; Benet Z; Wong A; Negri GL; Chang K; Sanchez R; Leung J; De Freitas N; Luu T; Schanin J; Youngblood BA
Allergy; 2024 Mar; 79(3):629-642. PubMed ID: 38186079
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation.
Schanin J; Gebremeskel S; Korver W; Falahati R; Butuci M; Haw TJ; Nair PM; Liu G; Hansbro NG; Hansbro PM; Evensen E; Brock EC; Xu A; Wong A; Leung J; Bebbington C; Tomasevic N; Youngblood BA
Mucosal Immunol; 2021 Mar; 14(2):366-376. PubMed ID: 32814824
[TBL] [Abstract][Full Text] [Related]
3. The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation.
Korver W; Wong A; Gebremeskel S; Negri GL; Schanin J; Chang K; Leung J; Benet Z; Luu T; Brock EC; Luehrsen K; Xu A; Youngblood BA
Front Immunol; 2022; 13():833728. PubMed ID: 35154156
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils.
Smiljkovic D; Herrmann H; Sadovnik I; Gamperl S; Berger D; Stefanzl G; Eisenwort G; Hoermann G; Kopanja S; Dorofeeva Y; Focke-Tejkl M; Jaksch P; Hoetzenecker K; Szepfalusi Z; Valenta R; Arock M; Valent P
J Allergy Clin Immunol; 2023 Jan; 151(1):202-211. PubMed ID: 35953001
[TBL] [Abstract][Full Text] [Related]
5. Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells.
Yu Y; Blokhuis BRJ; Diks MAP; Keshavarzian A; Garssen J; Redegeld FA
Front Immunol; 2018; 9():2138. PubMed ID: 30294327
[TBL] [Abstract][Full Text] [Related]
6. Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells.
Schanin J; Korver W; Brock EC; Leung J; Benet Z; Luu T; Chang K; Xu A; De Freitas N; Luehrsen K; Brehm MA; Wong A; Youngblood BA
Commun Biol; 2022 Nov; 5(1):1226. PubMed ID: 36369358
[TBL] [Abstract][Full Text] [Related]
7. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
[TBL] [Abstract][Full Text] [Related]
8. Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells.
Cao Y; Rische CH; Bochner BS; O'Sullivan JA
Front Immunol; 2023; 14():1283370. PubMed ID: 37928558
[TBL] [Abstract][Full Text] [Related]
9. Siglec-9 is an inhibitory receptor on human mast cells in vitro.
Miralda I; Samanas NB; Seo AJ; Foronda JS; Sachen J; Hui Y; Morrison SD; Oskeritzian CA; Piliponsky AM
J Allergy Clin Immunol; 2023 Sep; 152(3):711-724.e14. PubMed ID: 37100120
[TBL] [Abstract][Full Text] [Related]
10. Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases.
Metz M; Kolkhir P; Altrichter S; Siebenhaar F; Levi-Schaffer F; Youngblood BA; Church MK; Maurer M
Allergy; 2024 Jan; 79(1):37-51. PubMed ID: 37605867
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.
Yokoi H; Choi OH; Hubbard W; Lee HS; Canning BJ; Lee HH; Ryu SD; von Gunten S; Bickel CA; Hudson SA; Macglashan DW; Bochner BS
J Allergy Clin Immunol; 2008 Feb; 121(2):499-505.e1. PubMed ID: 18036650
[TBL] [Abstract][Full Text] [Related]
12. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
[TBL] [Abstract][Full Text] [Related]
13. Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.
O'Sullivan JA; Youngblood BA; Schleimer RP; Bochner BS
Semin Immunol; 2023 Sep; 69():101799. PubMed ID: 37413923
[TBL] [Abstract][Full Text] [Related]
14. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.
Youngblood BA; Brock EC; Leung J; Falahati R; Bochner BS; Rasmussen HS; Peterson K; Bebbington C; Tomasevic N
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465299
[TBL] [Abstract][Full Text] [Related]
15. Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice.
Wei Y; Chhiba KD; Zhang F; Ye X; Wang L; Zhang L; Robida PA; Moreno-Vinasco L; Schnaar RL; Roers A; Hartmann K; Lee CM; Demers D; Zheng T; Bochner BS; Zhu Z
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577572
[TBL] [Abstract][Full Text] [Related]
16. Discovery, Function, and Therapeutic Targeting of Siglec-8.
Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
[TBL] [Abstract][Full Text] [Related]
17. AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice.
Youngblood BA; Brock EC; Leung J; Falahati R; Bryce PJ; Bright J; Williams J; Shultz LD; Greiner DL; Brehm MA; Bebbington C; Tomasevic N
Int Arch Allergy Immunol; 2019; 180(2):91-102. PubMed ID: 31401630
[TBL] [Abstract][Full Text] [Related]
18. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
[TBL] [Abstract][Full Text] [Related]
20. Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells.
Robida PA; Rische CH; Morgenstern NB; Janarthanam R; Cao Y; Krier-Burris RA; Korver W; Xu A; Luu T; Schanin J; Leung J; Rothenberg ME; Wechsler JB; Youngblood BA; Bochner BS; O'Sullivan JA
Cells; 2022 Mar; 11(7):. PubMed ID: 35406705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
